Nom du produit:2,6-Difluoro-3-nitrobenzoic acid
IUPAC Name:2,6-difluoro-3-nitrobenzoic acid
- CAS：83141-10-0
- Formule moléculaire：C7H3F2NO4
- Pureté：95%
- Numéro de catalogue：CM160614
- Poids moléculaire：203.1
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:83141-10-0
- Formule moléculaire:C7H3F2NO4
- Point de fusion:-
- Code SMILES:O=C(O)C1=C(F)C=CC([N+]([O-])=O)=C1F
- Densité:
- Numéro de catalogue:CM160614
- Poids moléculaire:203.1
- Point d'ébullition:335.5°C at 760 mmHg
- N° Mdl:MFCD00119291
- Stockage:Keep in a tight container and store at ambient temperature，protect from light
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Plixorafenib
- FORE Biotherapeutics’s Plixorafenib (PLX-8394) is a next-generation, orally selective inhibitor and specific dimer breaker of BRAF protein under clinical development. Its favorable efficacy and tolerability are updated in the recently presented phase 1/2a results in BRAF V600 advanced solid tumors. Plixorafenib was designed to target a wide range of BRAF mutations while sparing wild type forms of RAF. It has been granted Fast Track Designation and Orphan Drug Designation from the U.S. FDA.
Recherche 
+86 21 5895 0110 
